Promsuk Jutabha
Tochigi, 3210293, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Retraction notice to "Nephroprotective potential of Panduratin A against colistin-induced renal injury via attenuating mitochondrial dysfunction and cell apoptosis" [Biomedicine & Pharmacotherapy 148 (2022) 112732].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 23, 2026
Potential Interaction of Pinocembrin with Drug Transporters and Hepatic Drug-Metabolizing Enzymes.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 28, 2024
Benzbromarone Analog SAR: Potent hURAT1 (SLC22A12) Inhibitors and Drug Transporter Interaction Studies.
Journal: Drug design, development and therapy
Published: June 26, 2024
Discovery of a chalcone derivative as an anti-fibrotic agent targeting transforming growth factor-β1 signaling: Potential therapy of renal fibrosis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 23, 2023
Interaction of buspirone and its major metabolites with human organic cation transporters.
Journal: Fundamental & clinical pharmacology
Published: October 07, 2022
Nephroprotective potential of Panduratin A against colistin-induced renal injury via attenuating mitochondrial dysfunction and cell apoptosis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 11, 2021
LAT1-specific inhibitor is effective against T cell-mediated allergic skin inflammation.
Journal: Allergy
Published: August 13, 2019
Catalytic asymmetric synthesis of α-methyl-p-boronophenylalanine.
Journal: Bioorganic & medicinal chemistry letters
Published: December 28, 2017
Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor tofogliflozin.
Journal: Diabetes, obesity & metabolism
Published: August 08, 2017
The uricosuric effects of dihydropyridine calcium channel blockers in vivo using urate under-excretion animal models.
Journal: Journal of pharmacological sciences
Published: August 04, 2017
Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: March 29, 2017
Last Updated: 09/26/2026